Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine

ClinicalTrials.gov ID: NCT04152083

Public ClinicalTrials.gov record NCT04152083. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 11:22 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Parallel Group, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Subjects Experiencing an Acute Attack of Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of eptinezumab administered intravenously in participants experiencing an acute attack of migraine.

Study identification

NCT ID
NCT04152083
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
485 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 7, 2019 (Actual)
Primary completion
Jul 8, 2020 (Actual)
Completion
Jul 8, 2020 (Actual)
Last update posted
Aug 17, 2021

2019 – 2020

United States locations

U.S. sites
52
U.S. states
30
U.S. cities
51
Facility City State ZIP Site status
Alabama Clinical Therapeutics Birmingham Alabama 35235 —
Arizona Research Center Phoenix Arizona 85053 —
Baptist Health Center for Clinical Research Little Rock Arkansas 72205 —
Advanced Research Center Anaheim California 92805 —
The Neurology Center of Southern California - Carlsbad Carlsbad California 92011 —
Excell research Inc Oceanside California 92056 —
Anderson Clinical Research Redlands California 92374 —
University of Colorado Hospital Aurora Colorado 80045 —
Denver Neurological Clinic - Denver Denver Colorado 80210 —
Coastal Connecticut Research LLC New London Connecticut 06320 —
Ki Health Partners LLC, dba New England Institute for Clinical Research Stamford Connecticut 06905 —
The George Washington Medical Faculty Associates Washington D.C. District of Columbia 20052 —
Medicinae Doctor Clinical Hallandale Florida 33009 —
AGA Clinical trials Hialeah Florida 33012 —
Meridien Research - Maitland Maitland Florida 32751 —
Palm Beach Neurology and Premiere Research Institute West Palm Beach Florida 33407 —
Clinical Research of Central Florida Winter Haven Florida 33880 —
Office of Doctor Frank Berenson Atlanta Georgia 30328 —
iResearch Atlanta, LLC Decatur Georgia 30030 —
Meridian Clinical Research - Savannah Neurology Specialists Savannah Georgia 31405 —
Cedar Crosse Research Center Chicago Illinois 60607 —
College Park Family Care Center Physicians Overland Park Kansas 66212 —
Phoenix Medical Research Prairie Village Kansas 66208 —
Central Kentucky Research Associates Lexington Kentucky 40509 —
Boston Clinical Trials Boston Massachusetts 02131 —
MedVadis Research Corporation, LLC Waltham Massachusetts 02451 —
Michigan Head Pain and Neurological institute Ann Arbor Michigan 48104 —
Clinical Research Institute - Minneapolis Minneapolis Minnesota 55402 —
Headache Neurology Research Institute Ridgeland Mississippi 39157 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Clinvest Research Springfield Missouri 65810 —
Nevada Headache Institute Las Vegas Nevada 89113 —
Albuqerque Clinical Trials Albuquerque New Mexico 87102 —
Dent Neurologic Institute - Amherst Amherst New York 14226 —
Integrative Clinical Trials Brooklyn New York 11229 —
CTI Clinical Research center Cincinnati Ohio 45212 —
Aventiv Research - Columbus Columbus Ohio 43213 —
Hometown Urgent Care And Research - Huber Heights Dayton Ohio 45424 —
Neuro-Behavioral Clinical Research Inc North Canton Ohio 44720 —
Delricht Research Tulsa Oklahoma 74133 —
Summit Research Network Portland Oregon 97210 —
Frontier Clinical Rsearch LLC Smithfield Pennsylvania 15478 —
Coastal Carolina Research Center - Mount Pleasant Mt. Pleasant South Carolina 29464 —
Chattanooga Medical research LLC Chattanooga Tennessee 37404 —
WR-ClinSearch LLC Chattanooga Tennessee 37421 —
Holston Medical Group - Kingsport Kingsport Tennessee 37660 —
Ventavia Research Group, LLC Fort Worth Texas 76104 —
Texas Center for Drug Development Inc Houston Texas 77081 —
Ventavia Research Group, LLC Keller Texas 76248 —
J. Lewis Research, Inc. / Foothill Family Clinic Salt Lake City Utah 84109 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Neuroscience Group Neenah Wisconsin 54956 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04152083, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2021 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04152083 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →